Describing how your medicine will be uniquely differentiated in the market so that it has the highest probability to be:
Taken over all other alternatives
Our solution includes a HealthCare Differentiation Indicator and various Differentiation scores that compare your asset on pre-determined Disease Area parameters to
other current and future competing products.
Demonstrating how strongly your medicine addresses real unmet needs in the market for:
The MDA Methodology ensures optimal Label Claims are driven from Unmet Customer Needs.
Providing the likelihood your medicine will bring the highest Return on Investment (ROI) over other alternatives in your portfolio. The MDA Methodology includes an evaluation of:
How real the opportunity is - that your medicine directly addresses a significant unmet need
The likelihood your asset will win in the market against other alternatives
The financial worth of the life cycle investment